CIK 0001388320 · Non-accelerated filer<br>Smaller reporting company
Actinium Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ATNM
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 880378336
- Phone
- (646) 677-3870
- Business address
- 100 PARK AVE., 23RD FLOOR, NEW YORK, NY, 10017
- Former names
- Cactus Ventures, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2016-04-19 | Memorial Sloan-Kettering Cancer Center 10% owner | Sale | −500 | $2.01 | $1K | 5,644,441 |
| 2016-04-19 | Memorial Sloan-Kettering Cancer Center 10% owner | Sale | −11,751 | $2.01 | $24K | 5,632,690 |
| 2016-04-19 | Memorial Sloan-Kettering Cancer Center 10% owner | Sale | −2,500 | $2.02 | $5K | 5,630,190 |
| 2016-04-19 | Memorial Sloan-Kettering Cancer Center 10% owner | Sale | −2,500 | $2.03 | $5K | 5,627,690 |
| 2016-04-19 | Memorial Sloan-Kettering Cancer Center 10% owner | Sale | −4,800 | $2.04 | $10K | 5,622,890 |
| 2016-04-19 | Memorial Sloan-Kettering Cancer Center 10% owner | Sale | −33,300 | $2.05 | $68K | 5,589,590 |
| 2016-04-19 | Memorial Sloan-Kettering Cancer Center 10% owner | Sale | −300 | $2.05 | $615 | 5,589,290 |
| 2016-04-19 | Memorial Sloan-Kettering Cancer Center 10% owner | Sale | −18,200 | $2.06 | $37K | 5,571,090 |
| 2016-04-19 | Memorial Sloan-Kettering Cancer Center 10% owner | Sale | −8,633 | $2.06 | $18K | 5,562,457 |
| 2016-04-19 | Memorial Sloan-Kettering Cancer Center 10% owner | Sale | −4,517 | $2.07 | $9K | 5,557,940 |
| 2016-04-19 | Memorial Sloan-Kettering Cancer Center 10% owner | Sale | −2,133 | $2.07 | $4K | 5,555,807 |
| 2016-04-19 | Memorial Sloan-Kettering Cancer Center 10% owner | Sale | −3,420 | $2.07 | $7K | 5,552,387 |
| 2016-04-18 | SETH SANDESH Director | Purchase | +5,000 | $1.98 | $10K | 23,500 |
| 2016-04-18 | SETH SANDESH Director | Purchase | +1,500 | $1.99 | $3K | 25,000 |
| 2016-04-15 | Nicholson, C. David Director | Grant or award · Options to purchase common stock | +75,000 | $1.99 | $149K | 75,000 |
| 2016-04-15 | DAVE KAUSHIK J CEO and Interim CFO | Grant or award · Options to purchase common stock | +400,000 | $1.99 | $796K | 400,000 |
| 2016-04-15 | SETH SANDESH Director | Purchase | +2,000 | $2.00 | $4K | 17,000 |
| 2016-04-15 | SETH SANDESH Director | Purchase | +1,500 | $2.01 | $3K | 18,500 |
| 2016-04-15 | SETH SANDESH Director | Grant or award · Options to purchase common stock | +500,000 | $1.99 | $995K | 500,000 |
| 2016-04-15 | CICIC DRAGAN Chief Medical Officer | Grant or award · Options to purchase common stock | +50,000 | $1.99 | $100K | 50,000 |
Page 14 of 16 · 316 trades